LRCX(LRCX)
LRCX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $34.78B | $41.39B | $46.37B | $48.12B | $55.75B |
| Low | $31.35B | $37.09B | $39.26B | $41.42B | $47.98B |
| High | $36.88B | $43.56B | $54.75B | $53.41B | $61.87B |
| EBITDA Avg | $14.09B | $17.22B | $20.24B | $21.27B | $25.99B |
| Low | $12.93B | $15.25B | $17.11B | $17.63B | $21.53B |
| High | $15.19B | $19.18B | $25.41B | $24.14B | $29.52B |
| EBIT Avg | $13.50B | $16.46B | $19.32B | $20.21B | $24.77B |
| Low | $12.34B | $14.50B | $16.19B | $16.57B | $20.30B |
| High | $14.60B | $18.42B | $24.50B | $23.08B | $28.29B |
| Net Income Avg | $11.84B | $14.47B | $16.99B | $17.78B | $21.82B |
| Low | $10.82B | $12.73B | $14.22B | $14.56B | $17.86B |
| High | $12.82B | $16.20B | $21.58B | $20.32B | $24.93B |
| EPS Avg | $9.48 | $11.76 | $13.66 | $14.10 | $17.30 |
| Low | $8.58 | $10.09 | $11.28 | $11.55 | $14.17 |
| High | $10.16 | $12.85 | $17.11 | $16.11 | $19.77 |
| Analysts (Rev / EPS) | 22 / 21 | 20 / 17 | 14 / 9 | 11 / 3 | 6 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $8.13B | $8.53B | $8.83B | $9.26B | $9.60B | $10.04B | $10.32B | $10.73B |
| Low | $8.03B | $8.14B | $8.45B | $8.87B | $9.19B | $9.62B | $9.88B | $10.27B |
| High | $8.18B | $8.85B | $9.17B | $9.62B | $9.97B | $10.43B | $10.72B | $11.14B |
| EBITDA Avg | $3.26B | $3.47B | $3.63B | $3.86B | $4.07B | $4.31B | $4.47B | $4.69B |
| Low | $3.17B | $3.28B | $3.44B | $3.66B | $3.86B | $4.08B | $4.23B | $4.44B |
| High | $3.32B | $3.64B | $3.80B | $4.04B | $4.27B | $4.52B | $4.68B | $4.91B |
| EBIT Avg | $3.13B | $3.33B | $3.49B | $3.71B | $3.91B | $4.14B | $4.29B | $4.50B |
| Low | $3.04B | $3.14B | $3.30B | $3.50B | $3.70B | $3.91B | $4.05B | $4.25B |
| High | $3.19B | $3.51B | $3.66B | $3.89B | $4.11B | $4.35B | $4.50B | $4.73B |
| Net Income Avg | $2.75B | $2.93B | $3.06B | $3.26B | $3.44B | $3.64B | $3.77B | $3.96B |
| Low | $2.67B | $2.76B | $2.89B | $3.08B | $3.25B | $3.44B | $3.56B | $3.74B |
| High | $2.80B | $3.08B | $3.22B | $3.42B | $3.61B | $3.82B | $3.96B | $4.16B |
| EPS Avg | $2.18 | $2.32 | $2.43 | $2.58 | $2.73 | $2.89 | $2.99 | $3.14 |
| Low | $2.12 | $2.19 | $2.29 | $2.44 | $2.58 | $2.73 | $2.83 | $2.97 |
| High | $2.22 | $2.44 | $2.55 | $2.71 | $2.86 | $3.03 | $3.14 | $3.30 |
| Analysts (Rev / EPS) | 16 / 16 | 16 / 17 | 8 / 7 | 8 / 13 | 15 / 7 | 11 / 7 | 7 / 8 | 7 / 8 |